Urinary 6-sulphatoxymelatonin excretion of rats is not changed by 24 hours of exposure to a horizontal 50-Hz, 100-μt magnetic field

Electro- and Magnetobiology

Volumn 18, Issue 1, 1999, Pages 23-31

  Bakos, József ^a,b   Nagy, Noémi ^a   Thuróczy, György ^a   Szabó, László D ^a  

^a National Research Institute for Radiobiology and Radiohygiene Budapest   (Hungary)

^b Natl Frederic Joliot Curie Res I   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

RATTUS NORVEGICUS;

EID: 0347417101     PISSN: 10619526     EISSN: None     Source Type: Journal    
DOI: 10.3109/15368379909012897     Document Type: Article

References (35)

1. Feychting, M., Schulgen, G., Olsen, J.H., and Ahlbom, A.: Magnetic fields and childhood cancer - a pooled analysis of two Scandinavian studies, Eur. J. Cancer 31A, 2035-2039, 1995.
2. Wertheimer, N. and Leeper, E.: Electrical wiring configurations and childhood cancer, Am. J. Epidemiol. 109, 273-284, 1979.
3. Stevens, R.G. and Davis, S.: The melatonin hypothesis: electric power and breast cancer, Environ. Health. Perspect. 104(suppl. 1), 135-140, 1996.
4. Gurney, J.G., Mueller, B.A., Davis, S., Schwartz, S.M., Stevens, R.G., and Lopecky, K.J.: Childhood brain tumor occurrence in relation to residential power line configurations, electric heating sources, and electric appliance use, Am. J. Epidemiol. 143, 120-128, 1996.
5. Mevissen, M., Lerchl, A., and Löscher, W.: Study on pineal function and DMBA-induced breast cancer formation in rats during exposure to a 100-mG, 50 Hz magnetic field, J. Toxicol. Environ. Health 48, 169-185, 1996.
6. Mevissen, M., Lerchl, A., Szamel, M., and Löscher, W.: Exposure of DMBA-treated female rats in a 50 Hz, 50μTesla magnetic field: effects on mammary tumor growth, melatonin levels, and T lymphocyte activation, Carcinogenesis 17, 903-910, 1996.
7. Reiter, R.J.: Melatonin: that ubiquitously acting pineal hormone, News Physiol. Sci. 6, 223-227, 1991.
8. Deacon, S. and Arendt, J.: Adapting to phase shifts, I. An experimental model for jet lag and shift work, Physiol. Behav. 59, 665-673, 1996.
9. Deacon, S. and Arendt, J.: Adapting to phase shifts, II. Effects of melatonin and conflicting light treatment, Physiol. Behav. 59, 675-682, 1996.
10. Skene, D.J., Deacon, S., and Arendt, J.: Use of melatonin in circadian rhythm disorders and following phase shifts, Acta Neurobiol. Exp. 56, 359-362, 1996.
11. Bergiannaki, J.D., Paparrigopoulos, T.J., and Stefanis, C.N.: Seasonal pattern of melatonin excretion in humans: relationship to daylength variation rate and geomagnetic field fluctuations, Experientia 52, 253-258, 1996.
12. Schulz, P., Chardo, F., Degli Agosti, R., Schaad, N., and Rivest, R.W.: Parallel nocturnal secretion of melatonin and testosterone in the plasma of normal man, J. Pineal Res. 19, 16-22, 1995.
13. Touitou, Y., Févre, M., Lagoguey, M., Carayon, A., Bogdan, A., Reinberg, A., Beck, H., Cesselin, F., and Touitou, C: Age- and mental health-related circadian rhythms of plasma levels of melatonin, prolactin, luteinizing hormone and follicle-stimulating hormone in man, J. Endocrinol. 91, 467-475, 1981.
14. Skwarlo-sonta, K.: Functional connection between the pineal gland and immune system, Acta Neurobiol. Exp. 56, 341-357, 1996.
15. Conti, A. and Maestroni, G.J.M.: The clinical neuroimmunotherapeutic role of melatonin in oncology, J. Pineal Res. 19, 103-110, 1995.
16. Maestroni, G.J.M.: Melatonin as a therapeutic agent in experimental endotoxic shock, J. Pineal Res. 20, 84-89, 1996.
17. Brackowski, R., Zubelewicz, B., Romanowski, W., Lissoni, P., Barni, S., Tancini, G., and Maestroni, G.J.M.: Preliminary study on modulation of the biological effects of tumor necrsosi factor-alpha in advanced cancer patients by the pineal hormone melatonin, J. Biol. Regul. Homeost. Agents 8, 77-80, 1994.
18. Massion, A.O., Teas, J., Herbert, J.R., Wertheimer, M.D., and Kabat-Zinn, J.: Meditation, melatonin and breast/prostate cancer: hypothesis and preliminary data, Med. Hypotheses 44, 39-46, 1995.
19. Reiter, R.J.: Oxygen radical detoxification processes during aging: the functional importance of melatonin, Aging Clin. Exp. Res. 7, 340-351, 1995.
20. Sewerynek, E., Ortiz, G.G., Reiter, R.J., Pablos, M.I., Melchiorri, D., and Daniels, W.M.U.: Lipopolysaccharide-induced DNA damage is greatly reduced in rats treated with the pineal hormone melatonin, Mol. Cell. Endocrinol. 117, 183-188, 1996.
21. Hätönen, T., Alila, A., and Laakso, M-L.: Exogenous melatonin fails to counteract the light-induced phase delay of human melatonin rhythm, Brain Res. 710, 125-130, 1996.
22. Laakso, M-L., Hätönen, T., and Alila, A.: Uncoupling of the pineal melatonin synthesis of rats from the circadian regulation, Neurosci. Lett. 179, 5-8, 1994.
23. Selmaoui, B. and Touitou, Y.: Sinusoidal 50-Hz magnetic fields depress rat pineal NAT activity and serum melatonin, role of duration and intensity of exposure, Life Sci. 57, 1351-1358, 1995.
24. Kato, M., Honma, K., Shigemitsu, T., and Shiga, Y.: Circularly polarized 50-Hz magnetic fields exposure reduces pineal gland and blood melatonin concentration of Long-Evans rats, Neurosci. Lett. 166, 59-62, 1994.
25. Duchene, A.S., Lakey, J.R., and Repachoili, M.H.: IRPA/INIRC Guidelines on Protection Against Non-ionizing Radiation, Pergamon Press, Elmsford, NY, 1991.
26. Bakos, J., Nagy, N., Thuróczy, G., and Szabó, L.D.: Sinusoidal 50 Hz, 500μT magnetic field has no acute effect on urinary 6-sulphatoxymelatonin in Wistar rats, Bioelectromagnetics 76, 377-380, 1995.
27. Selmaoui, B., Lambrozo, J., and Touitou, Y.: Magnetic fields and pineal function in humans: evaluation of nocturnal acute exposure to extremely low frequency magnetic fields on serum melatonin and urinary 6-sulfatoxymelatonin circadian rhythms, Life Sci. 58, 1539-1549, 1996.
28. Stieglitz, A., Speigelhalter, F., Klante, G., and Heldmayer, G.: Urinary 6-sulphatoxy melatonin excretion reflects pineal melatonin secretion in the Djungarian hamster (Phodopus sungorus), J. Pineal Res. 18, 69-76, 1995.
29. Pohjanvirta, R., Laitinen, J., Vakkuri, O., Linden, J., Kokkola, T., Unkila, M., and Tuomisto, J.: Mechanisms by which 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) reduces circulating melatonin levels in the rat, Toxicology 107, 85-97, 1996.
30. Vakkuri, O., Leppäluoto, J., and Vuolteenaho, O.: Development and validation of a melatonin radioimmunoassay using radioiodinated melatonin as tracer, Acta Endocrinol. 106, 152-157, 1984.
31. Aldhous, M.E. and Arendt, J.: Radioimmunoassay for 6-sulphatoxymelatonin in urine using an iodinated tracer, Ann. Clin. Biochem. 25, 298-303, 1988.
32. Bartsch, H., Bartsch, C., Mecke, D., and Lippert, T.H.: Seasonality of pineal melatonin production in the rat: possible synchronization by the geomagnetic field, Chronobiol. Int. 11, 21-26, 1994.
33. Kato, M., Honma, K., Shigemitsu, T., and Shiga, Y.: Horizontal or vertical 50 Hz, l-μT magnetic fields have no effect on pineal gland or plasma melatonin concentration of albino rats, Neurosci. Lett. 168, 205-208, 1994.
34. Bakos, J., Nagy, N., Thuróczy, G., and Szabó, L.D.: Urinary 6-sulphatoxymelatonin excretion is increased in rats after 24 hours of exposure to vertical 50 Hz, 100 μT magnetic field, Bioelectromagnetics 18, 190-192, 1997.
35. Yellon, S.M.: 60-Hz magnetic field exposure effects on the melatonin rhythm and photoperiod control of reproduction, Am. J. Physiol. 270, E816-E821, 1996.